Overview

Antibiotic Prophylaxis in Transurethral Prostate Resection (TURP) and Transurethral Bladder Tumour Resection (TURB)

Status:
Completed
Trial end date:
2019-12-23
Target enrollment:
Participant gender:
Summary
To investigate the use of antibiotic prophylaxis in patients undergoing TURP and TURB. The investigators set up a prospective, randomized controlled trial in which (after exclusion of risk factors) patients will be randomized in receiving levofloxacin (Tavanic) orally or no antibiotics. The exclusion criteria for TURP are a pre-operative transurethral catheter or > 100 urinary white blood cells in the pre-operative urine sample. The exclusion criteria for TURB are a pre-op catheter or clinical signs of infection.
Phase:
N/A
Details
Lead Sponsor:
Jessa Hospital
Treatments:
Anti-Bacterial Agents
Levofloxacin
Ofloxacin